Faculty & Scientific Staff

Jerry Nepom

Gerald Nepom, MD, PhD

Emeritus Member, Center for Interventional Immunology; ITN Senior Advisor
Immune Tolerance Network

Background Information

Dr. Nepom received his bachelor’s degree in Biochemistry from Harvard in 1972 and doctorates from the University of Washington, receiving his PhD in Biochemistry in 1977 and his MD in 1978. After post-doctoral work in immunogenetics in the Department of Pathology at Harvard Medical School, he returned to Seattle, joining the Fred Hutchinson Cancer Research Center and the University of Washington Medical School Faculty in 1982. Since 1985 he has been a Member of the Benaroya Research Institute at Virginia Mason (BRI) and served as Director of BRI from 1985 through 2015. Dr. Nepom also served as Director of the Immune Tolerance Network (ITN), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) from 2010 to 2022. He is currently an Emeritus Faculty Member of BRI and Senior Advisor to ITN.

Area Of Research

Dr. Nepom's interests are focused on identifying and understanding molecular and genetic mechanisms contributing to pathogenesis of autoimmune disorders and using this information to evaluate autoreactive T cell lineage and fate determination. Translational and clinical applications include development and use of immunological monitoring tools for predicting disease susceptibility and response to therapy in clinical trials, with special emphasis on type 1 diabetes.

Related Stories

Blog Main Image - 3D Tetramer Original
January 12, 2022

The Power of Tetramers: A Tool Developed by Bill Kwok, PhD

Bill Kwok, PhD, has made groundbreaking discoveries and built a tool that’s fueled countless advances. But he makes his work and his path to BRI sound simple: Why study the minute details of the immune system? Well, he’s curious — he was always at the library as a kid.

Read Article
Blog Main Image - T1D Diabetes Medical Technology
August 31, 2021

Beyond Insulin: Beyond BRI's Quest to Stop Type 1 Diabetes

he discovery of insulin 100 years ago transformed type 1 diabetes (T1D) from a death sentence to a chronic illness. Yet T1D is still a relentless disease with no cure.

Read Article
Blog Main Image - EDITORIAL Debra Smith Sofia Smith
June 15, 2021

Hope for MS Powers Support for BRI

Debra Smith first learned about BRI when a friend invited her to the Boeing Classic Golf Tournament in the early 2010s. BRI’s work became personal when she was diagnosed with multiple sclerosis (MS) in 2013.

Read Article

News

Science in Seattle Logo

Science in Seattle: IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function

Read the Publication ➡

Biological 'atlas' shows dual personality for immune cells that cause type 1 diabetes

Read more ➡
Science in Seattle Logo

A New Clinical Trial on the Treatment of Multiple Sclerosis Starts Enrollment

Read news ➡